Developing a low-cost method for detecting proteins in diseases like Alzheimer's and AIDS
Low-Cost Platform for Ultrasensitive Fluorescent Immunoblot
['FUNDING_SBIR_2'] · AURAGENT BIOSCIENCE, LLC · NIH-11008719
This study is working on a new, affordable way to test for important proteins linked to diseases like Alzheimer's and AIDS, which could help doctors find these proteins more accurately and lead to better treatments for patients.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | AURAGENT BIOSCIENCE, LLC (nih funded) |
| Locations | 1 site (SAINT LOUIS, UNITED STATES) |
| Trial ID | NIH-11008719 on ClinicalTrials.gov |
What this research studies
This research focuses on creating a cost-effective platform for fluorescent immunoblot assays, which are essential for detecting and quantifying proteins related to various diseases, including Alzheimer's and AIDS. The approach aims to enhance the sensitivity of these assays, allowing for the detection of low concentrations of proteins and their modified forms. By improving the accuracy and efficiency of protein detection, this research could significantly advance our understanding of disease mechanisms and treatment responses. Patients may benefit from more precise diagnostic tools that can lead to better-targeted therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or AIDS who may benefit from improved diagnostic methods.
Not a fit: Patients with conditions unrelated to protein detection or those who do not require diagnostic testing may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with more accurate and sensitive diagnostic tests for conditions like Alzheimer's and AIDS.
How similar studies have performed: Other research has shown success in enhancing protein detection methods, indicating that this approach has the potential for significant advancements.
Where this research is happening
SAINT LOUIS, UNITED STATES
- AURAGENT BIOSCIENCE, LLC — SAINT LOUIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CRICK, SCOTT L — AURAGENT BIOSCIENCE, LLC
- Study coordinator: CRICK, SCOTT L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome, Acquired Immunodeficiency Syndrome, Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease